PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Independent Expert, St Albans, United Kingdom.\', \'INN Programme and Classification of Medical Products, INN/HPS/MHP, World Health Organization, 1211 Geneva, Switzerland.\', \'Therapeutic Goods Administration, Department of Health, Woden ACT 2606, Australia.\', \'Agencia Española de Medicamentos y Productos Sanitarios, Madrid 28022, Spain.\', \'Universidad CEU Cardenal Herrera, Alfara del Patriarca, 46113 Valencia, Spain.\', \'Health Canada, Health Products and Food Branch, Ottawa, Ontario K1A 0K9, Canada.\', \'Division Safety of Medicinal Products and Medical Devices, Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Paul-Ehrlich-Strasse 7, 63225 Langen, Germany.\', \'INN Programme and Classification of Medical Products, INN/HPS/MHP, World Health Organization, 1211 Geneva, Switzerland. Electronic address: baloccor@who.int.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(21)01528-010.1016/j.vaccine.2021.11.054
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34844820
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34844820>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34844820>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all